Dutch producer of standardised medicinal cannabis, supplying cannabis as an active pharmaceutical ingredient and raw material rather than as a consumer product. Founded in 1984 and the exclusive supplier to the Dutch medicinal cannabis programme from 2003, the company operates EU-GMP-certified facilities in the Netherlands and, since 2025, in Køge, Denmark. Its products are standardised so that each variety is genetically identical batch to batch with a consistent cannabinoid profile.
Bedrocan's Danish plant is a small facility with an outsized strategic point: it proves a standardised pharmaceutical cannabis process can be transferred to another jurisdiction and pass inspection first time.